Skip to content

Right Ventricular Defibrillation Lead Select Site Study

Right Ventricular Defibrillation Lead Select Site Study

Status
UNKNOWN
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT00385749
Enrollment
98
Registered
2006-10-11
Start date
2006-10-31
Completion date
2008-12-31
Last updated
2007-11-01

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Heart Failure, Congestive, Tachycardia, Ventricular

Keywords

Implanted cardioverter defibrillator, congestive heart failure, right ventricular lead placement, select site pacing

Brief summary

This study will compare single coil right ventricular defibrillation leads for implanted cardioverter/defibrillators (ICDs) in the apical and high septal locations. It is hypothesized that RV septal positions are at least as good as apical positions using formally measured defibrillation thresholds(DFTs), and that they may have long term advantages in reducing left ventricular dysfunction.

Detailed description

The new studies Right Ventricular Lead/Select Site Registry and Right Ventricular Lead/Select Site Registry: Acute Study are studies designed to look at alternate lead locations for defibrillation leads for ICDs. The registry is designed to capture data from patients who have already undergone implant, so as to be able to publish long term data on defibrillation thresholds, pacing thresholds and left ventricular function. This will include both patients from the acute study, and those patients in whom leads have already been placed, and the exact lead location is known. The acute study is designed to directly compare defibrillation thresholds in the apical location versus the interventricular septal location for defibrillation leads. This study involves a direct comparison of two different sites in the same patient; using defined criteria for implant location (see protocol). The acute study is anticipated to enroll 34 patients, but the registry to collect ongoing data will be larger, encompassing previously implanted patients, with an expected sample size of 61 total in the registry for data collection.

Interventions

DEVICERV apical vs RV septal defibrillation threshold testing

Sponsors

Medtronic
CollaboratorINDUSTRY
Associates in Cardiology, PA
Lead SponsorOTHER

Study design

Allocation
NON_RANDOMIZED
Intervention model
CROSSOVER
Primary purpose
TREATMENT
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
21 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* Standard indications for ICD placement (AHA/ACC guidelines)

Exclusion criteria

* Inability to consent * age less than 21 years * inability to participate in study follow-up

Design outcomes

Primary

MeasureTime frame
Acute defibrillation thresholds

Secondary

MeasureTime frame
pacing thresholds
sensing thresholds
LV function (LVEF)
NYHA class
weight
LV diameter

Countries

United States

Contacts

Primary ContactMichael A Lincoln, MD
mlincoln@associatesincardiology.com301-681-5700

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026